LTR Pharma Limited (AU:LTP) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
LTR Pharma Limited has partnered with Men’s Health Downunder to provide its innovative erectile dysfunction treatment, SPONTAN®, through an established pharmacy network in Australia. This collaboration leverages Men’s Health Downunder’s extensive referral network and is a strategic step in commercializing SPONTAN®, aiming for broader market access by early 2025. The partnership underscores LTR Pharma’s commitment to enhancing men’s health through trusted healthcare providers.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue